クリングルファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4884/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/09/30 | 日証協 | 732,800株 | +4% | 183,200株 | +64.3% | 817,229株 | -0.77% | 72,900株 | +266.33% |
2022/09/22 | 日証協 | 704,600株 | +0.21% | 111,500株 | -76.93% | 823,530株 | +1.74% | 19,900株 | -71.89% |
2022/09/16 | 日証協 | 703,100株 | +7% | 483,400株 | -6.54% | 809,430株 | +0.76% | 70,800株 | +12.2% |
2022/09/09 | 日証協 | 657,100株 | +9.46% | 517,200株 | +51.14% | 803,330株 | +6.78% | 63,100株 | -83.82% |
2022/09/02 | 日証協 | 600,300株 | +3.48% | 342,200株 | +116.86% | 752,330株 | +3.28% | 390,012株 | +86.61% |
2022/08/26 | 日証協 | 580,100株 | +6.34% | 157,800株 | -55.02% | 728,418株 | +30.61% | 209,002株 | +74.44% |
2022/08/19 | 日証協 | 545,500株 | +7.42% | 350,800株 | +1546.95% | 557,716株 | +5.01% | 119,810株 | +524.01% |
2022/08/12 | 日証協 | 507,800株 | -0.68% | 21,300株 | -86.79% | 531,106株 | -0.95% | 19,200株 | -68.68% |
2022/08/05 | 日証協 | 511,300株 | +8.9% | 161,300株 | -40.61% | 536,206株 | +2.21% | 61,300株 | -49.51% |
2022/07/29 | 日証協 | 469,500株 | +11.44% | 271,600株 | +4.1% | 524,608株 | +9.24% | 121,400株 | +78.53% |
2022/07/22 | 日証協 | 421,300株 | +13.19% | 260,900株 | -47.06% | 480,229株 | +8.22% | 68,000株 | -78.5% |
2022/07/15 | 日証協 | 372,200株 | +196.1% | 492,800株 | +572.31% | 443,772株 | +10.47% | 316,217株 | +21.04% |
2022/07/08 | 日証協 | 125,700株 | +39.36% | 73,300株 | -9.39% | 401,727株 | +9.16% | 261,256株 | +16.74% |
2022/07/01 | 日証協 | 90,200株 | +21.4% | 80,900株 | +964.47% | 368,001株 | -1.63% | 223,800株 | +111.53% |
2022/06/24 | 日証協 | 74,300株 | -7.47% | 7,600株 | -15.56% | 374,113株 | -1.06% | 105,800株 | -48.11% |
2022/06/17 | 日証協 | 80,300株 | -1.71% | 9,000株 | -33.33% | 378,113株 | -3.57% | 203,900株 | -10.92% |
2022/06/10 | 日証協 | 81,700株 | +2% | 13,500株 | +3275% | 392,113株 | -1.41% | 228,900株 | +87.01% |
2022/06/03 | 日証協 | 80,100株 | -2.2% | 400株 | -84% | 397,713株 | -0.38% | 122,400株 | -49.11% |
2022/05/27 | 日証協 | 81,900株 | +2.76% | 2,500株 | -32.43% | 399,215株 | -2.42% | 240,502株 | +45.23% |
※株式分割は考慮していませんのでご注意ください。
Page Top